Toxicology Letters

Papers
(The H4-Index of Toxicology Letters is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
S05-03 The development of a human liver-based In Vitro test battery to detect liver steatotic potential of chemicals from various applicability domains66
P02-46 Cultivation conditions in microfluidic environments: insights from 2D and 3D cell culture models55
P01-39 Mitochondrial toxicity screening to support the R&D crop protection pipeline40
P07-09 Spatio-temporal multi-omics analysis of lung tissue and matched biofluids identifies circulatory safety biomarkers for monitoring inhaled drug induced lung injury39
P02-47 A rat in vitro 3D airway model for translational toxicology38
S20-04 Generic pharmacokinetic models for mother-to-offspring transfer of environmental chemicals36
P09-10 The synthetic cannabinoid ADB-FUBINACA disrupts mitochondrial biogenesis of NG108-15 neuroblastoma cells during neuronal differentiation at human-relevant concentrations33
P12-13 Role of endoplasmic reticulum stress in sunitinib-induced hepatotoxicity30
P02-26 Optimized iPSC-derived hepatocytes offer a novel liver cell model for in vitro predictive toxicity and drug efficacy studies29
P08-03 Comprehensive digital documentation and computer-assisted evaluation of the skeleton of Alizarin Red and Alcian Bluestained rat foetuses27
P17-07 Prenatal exposure to acrylamide and metabolic status at 20 years of age: a prospective biomarker-based cohort study from Denmark26
The toxicology of inhaled nanomaterials and examples of risk assessment and regulation25
P21-54 Searching for links in binding patterns among androgen and progesterone receptor ligands25
P19-50 In-chemico reactivity methods based on molecular initiating event of skin sensitization: refinements and possible application to cosmetic formulations25
P07-18 Acute phase proteins in Göttingen minipigs: comparison between haptoglobin, Pig-MAPP and CRP in the context of a vaccine study25
P07-05 Miniaturization of haematology sampling in rodents on toxicology studies25
P14-06 The cytotoxicity of bortezomib in AC16 cardiac cells and possible therapeutic options involving Nrf223
P02-22 Establishment of a microfluidic neurotoxicity screening model using human iPSCs-differentiated motor neurons within the New Approach Methodologies for chemical safety developed for Precision To22
P13-36 In silico analysis of positive and negative effects of isothiocyanates in breast cancer22
P19-03 Integration of transcriptomics data for ED assessments using an Adverse Outcome Pathway Network approach22
P08-10 Advancing the use of New Approach Methodologies for assessing teratogenicity using a tiered approach: metabolism consideration to improve the human relevance22
Toxicokinetic relationship between the adducts in globin and their cleavage products in the urine: Implications for human biomonitoring21
S23-02 Assessment and modelling of metabolites: the conazole case study21
P20-27 Zinc suphide – considerations and challenges for acute inhalation toxicity testing and classification under REACH21
LP-10 Comparative analysis of occupational exposure limits (OELs) for inhibiting RNA therapeutics21
P06-04 Advancing bladder cancer detection: unveiling a novel urinary biomarker panel through metabolomics21
0.53143191337585